19 C
New York
Friday, June 9, 2023

There’s No Need To Panic Or Freeze When It Comes To Creative Medical Technology Holdings Inc. (NASDAQ: CELZ)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Creative Medical Technology Holdings Inc. (CELZ) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0122, or -1.94%, to $0.6161. The Creative Medical Technology Holdings Inc. has recorded 3,224 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.63 and fluctuated between $0.6500 as its day high and $0.6000 as its day low. The current market capitalization of Creative Medical Technology Holdings Inc. is $8.41M. A total of 0.78 million shares were traded on the day, compared to an average of 1.82M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CELZ has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 15 BUYs and 0 SELLs from insiders. Insiders purchased 124,000 shares during that period but sold 0.

In the most recent transaction, Warbington Timothy bought 10,000 shares of CELZ for 0.39 per share on Nov 22. After the transaction, the President & CEO now owns 112,087 company shares. In a previous transaction on Nov 21, Warbington Timothy bought 15,000 shares at 0.40 per share. CELZ shares that President & CEO owns now total 102,087.

Among the insiders who bought shares, Warbington Timothy acquired of 20,000 shares on Sep 27 at a per-share price of $0.50. This resulted in the President & CEO holding 87,087 shares of CELZ after the transaction. In another insider transaction, Finger Michael H. bought 2,000 shares at $0.50 per share on Sep 27. Company shares held by the Director now total 18,502.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CELZ in the last 3 months, the mean price target is $7.00 with high estimates of $7.00 and low estimates of $7.00. In terms of 52-week highs and lows, CELZ has a high of $1.60 and a low of $0.33.

As of this writing, CELZ has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.08. The company reported an EPS of -$0.53 in the last quarter, which was -657.10% lower than expectations of -$0.07.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CELZ’s latest balance sheet shows that the firm has $10.72M in Cash & Short Term Investments as of fiscal 2021. There were $788.70k in debt and $1.05M in liabilities at the time. Its Book Value Per Share was $1.05, while its Total Shareholder’s Equity was $10.22M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CELZ is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles